Related Experiment Videos
High-sensitivity C-reactive protein as a risk assessment tool for cardiovascular disease
1Department of Cardiology, University of Texas-MD Anderson Cancer Center, Houston, TX 77030-4095, USA. etyeh@mdanderson.org
Insights
High-sensitivity C-reactive protein (hs-CRP) is a key inflammation marker that predicts cardiovascular events, even in those without traditional risk factors. hs-CRP testing improves cardiovascular risk assessment and may be lowered by statins.
Area of Science:
- Cardiology
- Biochemistry
- Inflammation Research
Background:
- Cardiovascular events often occur without known risk factors.
- Traditional risk assessment may not capture all at-risk individuals.
- C-reactive protein (CRP) has emerged as a significant cardiovascular risk predictor.
Purpose of the Study:
- To evaluate high-sensitivity C-reactive protein (hs-CRP) as a predictor of cardiovascular events.
- To assess the role of hs-CRP in atherosclerosis and related conditions.
- To determine the clinical utility of hs-CRP testing in risk stratification.
Main Methods:
- Utilized high-sensitivity assays to measure hs-CRP levels.
- Correlated hs-CRP levels with incident and recurrent cardiovascular events.
- Examined the association of hs-CRP with metabolic syndrome and diabetes.
Main Results:
- hs-CRP is a potent predictor of first cardiovascular events, comparable to LDL cholesterol.
- hs-CRP independently predicts recurrent events in patients with coronary artery disease.
- Elevated hs-CRP is linked to metabolic syndrome and diabetes, especially in women.
Conclusions:
- hs-CRP is a valuable biomarker for inflammation and cardiovascular risk assessment.
- hs-CRP testing complements lipid screening and global risk assessment tools.
- Interventions like statin therapy can reduce hs-CRP, with ongoing research into event prevention.
Abstract:
Almost half of first cardiovascular events occur in individuals with no known risk factors. Attempts in the last decade to predict cardiovascular risk more accurately have led to the emergence of a novel risk factor, C-reactive protein (CRP), which has proved to be as good a risk predictor as low-density lipoprotein cholesterol. C-reactive protein is an index of inflammation that is now believed to promote directly all stages of atherosclerosis, including plaque rupture. As measured by high-sensitivity assays, high-sensitivity CRP (hs-CRP) also independently predicts recurrent events in patients with known coronary artery diseases. Recent evidence implicates hs-CRP, and thus inflammation, in the metabolic syndrome and diabetes mellitus, particularly in women. As a clinical tool for cardiovascular risk assessment, hs-CRP testing enhances information provided by lipid screening or global risk assessment. Statin therapy and other interventions can lower hs-CRP. Whether or not such reductions can prevent cardiovascular events is under investigation.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:30Coronary Artery Disease I: Introduction
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...